Cargando…
Prevalence of cardiovascular diseases in COVID-19 related mortality in the United States
BACKGROUND: Several cardiovascular disease (CVD) risk factors and sequelae have been associated with COVID-19. Little is known about the distribution of CVD conditions in COVID-19 related deaths in the US population. METHODS: The public-use dataset by CDC, “Conditions Contributing to COVID-19 Deaths...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585886/ https://www.ncbi.nlm.nih.gov/pubmed/36279944 http://dx.doi.org/10.1016/j.pcad.2022.09.002 |
_version_ | 1784813590783459328 |
---|---|
author | Vasudeva, Rhythm Challa, Abhiram Al Rifai, Mahmoud Polana, Tejasri Duran, Brent Vindhyal, Mohinder Lewis, Eldrin F. |
author_facet | Vasudeva, Rhythm Challa, Abhiram Al Rifai, Mahmoud Polana, Tejasri Duran, Brent Vindhyal, Mohinder Lewis, Eldrin F. |
author_sort | Vasudeva, Rhythm |
collection | PubMed |
description | BACKGROUND: Several cardiovascular disease (CVD) risk factors and sequelae have been associated with COVID-19. Little is known about the distribution of CVD conditions in COVID-19 related deaths in the US population. METHODS: The public-use dataset by CDC, “Conditions Contributing to COVID-19 Deaths, by State and Age, Provisional 2020-2021”, was abstracted as of August 1, 2021. A descriptive analysis was conducted to explore the overall and age-specific prevalence of various CVD and risk factors grouped by pre-specified ICD-10 codes amongst COVID-19 patient deaths. Respective trends over the duration of the pandemic were analyzed using the Mann-Kendall method, including time-periods before and after the introduction of vaccines in January 2021. All time-related analysis was conducted between March 2020 and June 2021. RESULTS: A total of 600,241 COVID-19 related deaths were reported between March 2020 and June 2021. Hypertensive diseases were the most prevalent (19.6%), followed by diabetes (15.9%), ischemic heart disease (IHD;10.9%), heart failure (7.7%), cardiac arrhythmias (7.5%), other diseases of the circulatory system (6.6%), cerebrovascular diseases (5%), and obesity (4.1%). While a significant downward trend was noted for hypertensive diseases over the course of the pandemic, cardiac arrhythmias, heart failure (HF), obesity, and other circulatory system diseases demonstrated a significant upward trend. Since the introduction of vaccines, the trends for heart failure and cardiac arrhythmias remained steady while having demonstrated a significant rise in the pre-vaccination time-period. While obesity and other diseases of the circulatory system predominated (>50%) amongst the CVD burden in the younger population (0–24 years and 25–34 years), the percentage occurrence of cardiac arrhythmias, hypertensive diseases, HF, and IHD increased with age. CONCLUSION: Hypertensive diseases, diabetes, and IHD were the most prevalent cardiovascular conditions amongst COVID-19 related deaths. These patterns varied by age. While the trend for hypertensive diseases declined over the course of the pandemic, cardiac arrhythmias, HF, obesity, and other diseases of the circulatory system demonstrated an upward trend. An important limitation is the source of the data being limited to death certificates. |
format | Online Article Text |
id | pubmed-9585886 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95858862022-10-21 Prevalence of cardiovascular diseases in COVID-19 related mortality in the United States Vasudeva, Rhythm Challa, Abhiram Al Rifai, Mahmoud Polana, Tejasri Duran, Brent Vindhyal, Mohinder Lewis, Eldrin F. Prog Cardiovasc Dis Article BACKGROUND: Several cardiovascular disease (CVD) risk factors and sequelae have been associated with COVID-19. Little is known about the distribution of CVD conditions in COVID-19 related deaths in the US population. METHODS: The public-use dataset by CDC, “Conditions Contributing to COVID-19 Deaths, by State and Age, Provisional 2020-2021”, was abstracted as of August 1, 2021. A descriptive analysis was conducted to explore the overall and age-specific prevalence of various CVD and risk factors grouped by pre-specified ICD-10 codes amongst COVID-19 patient deaths. Respective trends over the duration of the pandemic were analyzed using the Mann-Kendall method, including time-periods before and after the introduction of vaccines in January 2021. All time-related analysis was conducted between March 2020 and June 2021. RESULTS: A total of 600,241 COVID-19 related deaths were reported between March 2020 and June 2021. Hypertensive diseases were the most prevalent (19.6%), followed by diabetes (15.9%), ischemic heart disease (IHD;10.9%), heart failure (7.7%), cardiac arrhythmias (7.5%), other diseases of the circulatory system (6.6%), cerebrovascular diseases (5%), and obesity (4.1%). While a significant downward trend was noted for hypertensive diseases over the course of the pandemic, cardiac arrhythmias, heart failure (HF), obesity, and other circulatory system diseases demonstrated a significant upward trend. Since the introduction of vaccines, the trends for heart failure and cardiac arrhythmias remained steady while having demonstrated a significant rise in the pre-vaccination time-period. While obesity and other diseases of the circulatory system predominated (>50%) amongst the CVD burden in the younger population (0–24 years and 25–34 years), the percentage occurrence of cardiac arrhythmias, hypertensive diseases, HF, and IHD increased with age. CONCLUSION: Hypertensive diseases, diabetes, and IHD were the most prevalent cardiovascular conditions amongst COVID-19 related deaths. These patterns varied by age. While the trend for hypertensive diseases declined over the course of the pandemic, cardiac arrhythmias, HF, obesity, and other diseases of the circulatory system demonstrated an upward trend. An important limitation is the source of the data being limited to death certificates. Elsevier Inc. 2022 2022-10-21 /pmc/articles/PMC9585886/ /pubmed/36279944 http://dx.doi.org/10.1016/j.pcad.2022.09.002 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Vasudeva, Rhythm Challa, Abhiram Al Rifai, Mahmoud Polana, Tejasri Duran, Brent Vindhyal, Mohinder Lewis, Eldrin F. Prevalence of cardiovascular diseases in COVID-19 related mortality in the United States |
title | Prevalence of cardiovascular diseases in COVID-19 related mortality in the United States |
title_full | Prevalence of cardiovascular diseases in COVID-19 related mortality in the United States |
title_fullStr | Prevalence of cardiovascular diseases in COVID-19 related mortality in the United States |
title_full_unstemmed | Prevalence of cardiovascular diseases in COVID-19 related mortality in the United States |
title_short | Prevalence of cardiovascular diseases in COVID-19 related mortality in the United States |
title_sort | prevalence of cardiovascular diseases in covid-19 related mortality in the united states |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585886/ https://www.ncbi.nlm.nih.gov/pubmed/36279944 http://dx.doi.org/10.1016/j.pcad.2022.09.002 |
work_keys_str_mv | AT vasudevarhythm prevalenceofcardiovasculardiseasesincovid19relatedmortalityintheunitedstates AT challaabhiram prevalenceofcardiovasculardiseasesincovid19relatedmortalityintheunitedstates AT alrifaimahmoud prevalenceofcardiovasculardiseasesincovid19relatedmortalityintheunitedstates AT polanatejasri prevalenceofcardiovasculardiseasesincovid19relatedmortalityintheunitedstates AT duranbrent prevalenceofcardiovasculardiseasesincovid19relatedmortalityintheunitedstates AT vindhyalmohinder prevalenceofcardiovasculardiseasesincovid19relatedmortalityintheunitedstates AT lewiseldrinf prevalenceofcardiovasculardiseasesincovid19relatedmortalityintheunitedstates |